AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2023
Mar 17, 2023
29871_dirs_2023-03-17_4331146a-497f-40de-b16b-21eea6a5eebb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2023-03-15
Reporting Person: Marcus Jonathan L (Sr MD General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-15 | Common Stock Class A | A | 2636 | $182.67 | Acquired | 2636 | Direct |
Footnotes
F1: On March 15, 2023, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the terms and conditions of the CME Group Inc. Omnibus Stock Plan.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17